News from cepheid A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 29, 2020, 07:00 ET Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test

Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress...


Jun 09, 2020, 07:00 ET Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV

Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the...


Mar 21, 2020, 09:00 ET Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress...


Feb 28, 2020, 07:00 ET Cepheid and Sherlock Biosciences Establish Collaboration on New GeneXpert Tests for Infectious Diseases and Oncology Leveraging CRISPR Technology

Cepheid and Sherlock Biosciences today announced a research collaboration between the two companies to explore the development of new cutting-edge...


Feb 10, 2020, 07:00 ET Cepheid Announces Development of Test for New Coronavirus Strain (2019-nCoV)

Cepheid today announced that in response to the rapid outbreak of a new coronavirus strain, the Company is developing an automated molecular test for ...


Oct 02, 2019, 07:00 ET Cepheid Receives FDA Clearance for Xpert® BCR-ABL Ultra Test

Cepheid today announced that it has received clearance from the U.S. Food and Drug Administration for Xpert BCR-ABL Ultra for monitoring disease...


May 29, 2019, 07:00 ET Cepheid Receives FDA Clearance for Extragenital Claims for Xpert® CT/NG Test

Cepheid announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for testing throat and rectal specimens with...


Apr 15, 2019, 02:00 ET Cepheid Announces FleXible Cartridge Program

Cepheid today announced its FleXible Cartridge program to accelerate menu expansion in Europe and China through partnerships with selected Trusted...


Dec 20, 2018, 07:00 ET Cepheid Receives CE-IVD Clearance for Xpert® HBV Viral Load

Cepheid today announced the CE-IVD marking of Xpert HBV Viral Load, a new rapid test for the quantitation of Hepatitis B Virus (HBV) that delivers...


Sep 19, 2018, 07:00 ET Cepheid Receives CE-IVD clearance for Xpert HCV VL Fingerstick

Cepheid today announced the CE-IVD marking of Xpert HCV VL Fingerstick, the first molecular test to detect and quantify hepatitis C Virus (HCV) RNA...


Jul 26, 2018, 07:00 ET Cepheid Receives FDA Clearance and CLIA Waiver for Xpert® Xpress Flu/RSV Test

Cepheid announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Clinical Laboratory Improvement Amendments...


May 15, 2018, 07:00 ET FDA Clears Expanded Claims for 'Superbug' Test

Cepheid today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for expanded claims for Xpert® Carba-R, an...


May 02, 2018, 07:00 ET Cepheid Receives FDA Clearance and CLIA Waiver for Xpert Xpress Strep A

Cepheid announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and waiver under the Clinical Laboratory...


Feb 20, 2018, 07:00 ET New IDSA/SHEA Guidelines Highlight Critical Role of PCR Testing in C. difficile Diagnosis

Newly released IDSA/SHEA Clinical Practice Guidelines for C. difficile, a major cause of gastrointestinal infection, once again emphasize the need...


Jan 09, 2018, 07:00 ET Cepheid Receives FDA Clearance and CLIA Waiver for Xpert® Xpress Flu Test

Cepheid announced today it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Clinical Laboratory Improvement Amendments...


Oct 05, 2017, 07:00 ET Cepheid Expands Respiratory Disease Portfolio with Xpert Xpress Strep A

Cepheid announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market Xpert® Xpress Strep A. The test...


Feb 15, 2017, 06:00 ET Cepheid Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV

Cepheid today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market Xpert® Xpress Flu and Xpert Xpress...


Oct 27, 2016, 08:00 ET 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US

With the flu season fast approaching, healthcare providers no longer need to choose between a fast test result or an accurate test result for...


Oct 24, 2016, 08:00 ET Cepheid Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation

Cepheid (NASDAQ: CPHD) today announced that antitrust clearances have been received or the requisite waiting periods have expired, as applicable, in...


Oct 05, 2016, 04:05 ET New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring

There's now an easier way to confidently rule out bladder cancer recurrence, thanks to a new test from Cepheid (Nasdaq: CPHD), Xpert® Bladder Cancer...


Sep 15, 2016, 04:05 ET Cepheid Announces Expansion Of The Most Comprehensive Molecular C. Difficile Product Portfolio On The Market

Particularly perilous Clostridium difficile strains are now potentially easier to detect, thanks to expanded reporting of binary toxin (CDT) gene...


Sep 08, 2016, 04:05 ET Cepheid Targets Development of a Point of Care HIV Viral Load Test From a Few Drops of Blood

Millions of patients, including newborns, in primary health care settings could gain access to a potentially life-changing test for HIV viral load...


Sep 06, 2016, 06:30 ET Cepheid Agrees To Be Acquired By Danaher Corporation For $53 Per Share In Cash

Cepheid (NASDAQ: CPHD) today announced that it has entered into a definitive agreement with Danaher Corporation (NYSE: DHR) under which Danaher will...


Sep 06, 2016, 04:15 ET Cepheid's Xpert TV Now Cleared For Testing Symptomatic And Asymptomatic Men

Men in the United States can now have easier access to fast and accurate testing for a potentially dangerous sexually transmitted infection, thanks...


Jul 28, 2016, 04:05 ET Cepheid Reports Second Quarter 2016 Results

Cepheid (Nasdaq: CPHD) today reported revenue for the second quarter of 2016 of $146.0 million, representing growth of 10%, or 12% on a constant...